AGN-192172

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAGN-192172
Drug Alias NameAGN-192172
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A